Current Research Studies

Multicenter, Open-label, Phase 2, Extension Trial to Study the Long-Term Safety in Participants With PROS or Proteus Syndrome Who Are Currently Being Treated with Miransertib in Other Studies

ARQ_Extension

Phase: II
Clinicaltrials.gov ID: NCT04980872

What is the goal of the study?

Long term safety assessment in patients who previously participated in the ARQ092 study

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Jonathan Perkins
Study Team Member: Katie Carron, [email protected]